Navigation Links
Synthetic Biologics' Webcast Conference Call Set for 9:00 a.m. EST this Morning, December 9th
Date:12/9/2013

ROCKVILLE, Md., Dec. 9, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of product candidates focused on the prevention and treatment of serious infectious diseases and other diseases, will host a webcast conference call and webcast this morning at 9:00 a.m. EST to discuss the announcement made Saturday, December 7, 2013 on the worldwide license and option agreements it entered into with Cedars-Sinai Medical Center ("Cedars-Sinai") for the development of new drugs to target non-bacterial intestinal microorganism life forms known as archaea that are associated with chronic diseases such as irritable bowel syndrome (IBS), obesity and type 2 diabetes.

The full text of Saturday's announcement appears below.

Jeffrey Riley, Synthetic Biologics' Chief Executive Officer, will host the call. During the call, Mark Pimentel, M.D., FRCP(C), Director of the Gastrointestinal Motility Program at Cedars-Sinai, will provide an audio-visual presentation overview of the scientific basis and market opportunity of our new pathogen-specific approaches to archaea-associated diseases, such as, C-IBS, obesity and diabetes.

Interested parties should call 1-877-870-4263, (U.S. toll free), 1-855-669-9657 (Canada toll free), or +1-412-317-0790 (International), fifteen minutes before the start of the call to register. Registered callers on the toll free line may ask to be placed in the queue for the Question & Answer Session. The call will also be webcast over the Internet with a slide presentation at http://www.videonewswire.com/event.asp?id=97322. If you are unable to participate during the live conference call, the webcast will be available for replay at the same URL, http://www.videonewswire.com/ev
'/>"/>

SOURCE Synthetic Biologics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
3. Synthetic Biologics Reports Second Quarter 2012 Financial Results
4. Synthetic Biologics Initiates Development of Monoclonal Antibodies for Treatment of Acinetobacter Infections
5. The Use of New Replikins Synthetic Vaccines to Prevent Pandemics to be Presented at Influenza Congress Nov. 12 in Washington DC
6. Inovio Expands Synthetic Vaccine Intellectual Property License With University of Pennsylvania
7. Synthetic Biologics Closes Deal for Acquisition of C. difficile Infectious Disease Program
8. Inovios Synthetic Flu Vaccine Doubles Rate of Elderly Subjects Displaying Protective Immune Responses
9. Synthetic Biologics Reports that Flupirtine Sublicensee, Meda AB, to Initiate Phase II Fibromyalgia Clinical Trial in U.S.
10. Synthetic Biologics to Present at the 25th Annual ROTH Conference
11. What Will Thermo Fisher Scientific and Life Technologies $14 billion Merger hold for the Top Ten Suppliers of Synthetic Biology Technology and DNA Sequencing Landscape?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015 Zimmer Holdings, Inc. ... today announced that its Board of Directors has approved the ... second quarter of 2015. The cash dividend of ... 14, 2015, to stockholders of record as of the close ... are subject to approval of the Board of Directors and ...
(Date:5/5/2015)... Silver Creek Pharmaceuticals, Inc. announced today the ... from the National Institute of Health (NIH). ... based biotechnology company that discovers and develops ... disease. This award will be used to advance their ... a heart attack. Silver Creek,s Smart Growth ...
(Date:5/5/2015)... 2015  Trovagene, Inc. (NASDAQ:  TROV), a developer ... results for the three months ended March 31, ... we presented favorable clinical results at ASCO GI, ... our Precision Cancer Monitoring platform,s ability to detect ... lung cancers," said Antonius Schuh, Ph.D., chief executive ...
Breaking Medicine Technology:Silver Creek Pharmaceuticals Awarded NIH SBIR Grant for Smart Growth Factor Technology 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 4Trovagene, Inc. Announces First Quarter 2015 Financial Results 5Trovagene, Inc. Announces First Quarter 2015 Financial Results 6
... MORGANTOWN, W.Va., Jan. 11, 2011 A Blanchette ... the Journal of Neuroscience reveals underlying causes for ... identifies promising pharmaceutical solutions for the devastating condition ... the United States. The BRNI study is the ...
... Jan. 11, 2011 Hill-Rom Holdings, Inc. (NYSE: ... on Wednesday, January 26, 2011.  The company will host a ... 8 a.m. EST. Earnings Release:   Hill-Rom,s ... December 31, 2010, will be issued to the public after ...
Cached Medicine Technology:The Blanchette Rockefeller Neurosciences Institute Identifies Groundbreaking New Therapies for Prevention and Treatment of Alzheimer's Disease 2The Blanchette Rockefeller Neurosciences Institute Identifies Groundbreaking New Therapies for Prevention and Treatment of Alzheimer's Disease 3Hill-Rom Holdings, Inc. Hosts Fiscal 2011 First Quarter Earnings Webcast 2
(Date:5/6/2015)... In celebration of their twentieth anniversary, ... they will give away a deluxe human hair lace wig ... steps to enter on a third-party giveaway tool. The important ... can be the winner. , The hair is a crown, ... destination for such a jewel for the past 20 years. ...
(Date:5/6/2015)... 06, 2015 Qualidigm , ... has hired healthcare executive Ann Olson, RN, BSN, ... will lead Qualidigm’s growing home healthcare services and ... improve the quality, safety, and cost-effectiveness of healthcare ... from Interim HealthCare of North Haven, Inc., a ...
(Date:5/6/2015)... Pass, OR (PRWEB) May 06, 2015 ... for maintaining eye health as we age, is fully ... the Sharon Kleyne Hour™ Power of Water® radio show. ... the need to drink sufficient water each day. As ... Nature’s Tears® EyeMist® for dry eye, Kleyne has extensive ...
(Date:5/6/2015)... 2015 Chinese technology company, Elink-IOT, has ... to raise AUD$150,000 to finalize development of Watcher, the ... smart watch designed to help the owner keep track ... when the item is out of range. , ... the wearer and sends alerts on its E-paper display, ...
(Date:5/6/2015)... LINET Americas has been awarded the ... small business category. The award was given for outstanding ... is given on an annual basis to foreign owned ... to philanthropy. Since 1998, the Charlotte International Cabinet ... Mayor’s International Community Awards. The award was presented to ...
Breaking Medicine News(10 mins):Health News:PremierLaceWigs.com Human Hair Lace Wigs Giveaway Could Change Your Hairstyle 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 3Health News:National Eye Institute’s Eye Care as You Age report endorsed by fresh water advocate Sharon Kleyne – with one addition 2Health News:National Eye Institute’s Eye Care as You Age report endorsed by fresh water advocate Sharon Kleyne – with one addition 3Health News:Crowdfunding campaign Launched for World’s First Anti-Loss Smart Watch 2Health News:LINET Americas Wins The Mayor's International Community Award in Charlotte 2
... Dec. 10 N3 Oceanic, Inc. announced the addition of ... developed by cardiologist Dr. Jeffrey Shapiro, MD, Assistant Professor of ... and NYU Langone Medical Center, who has been giving the ... life-changing results. Dr. Shapiro states, Orosine is the most significant ...
... Global Med Technologies(R), Inc.,("Global Med" or the "Company") ... technology company, today announced that due to,inquiries from ... that was,received from Victory Park Capital Advisors, LLC ... Global Med,s Board of Directors to investigate various,business ...
... Botanical Council (ABC) has officially launched its Adopt-an-Herb program, ... ( Camellia sinensis ). For the next three years, ... ensure that abstracts (summaries) of the latest published scientific ... ABC,s HerbMedPro database, one of the most robust and ...
... Dec. 10 Genomma Lab Internacional,S.A.B. de C.V. (BMV: ... ("OTC") pharmaceuticals and personal care products company,announced today its ... growth without considering acquisitions in the range of 21% ... the range of 27% - 28%. These estimates,are ...
... stress of the economy,have you pulling your hair out? ... Now is the time to take a breather, rejuvenate, ... emotionally,physically and financially, which is why many spas are offering ... get the other half off,there is something for everyone. ...
... Dec. 10 Napo Pharmaceuticals, Inc. ("Napo"),is pleased ... for the license of crofelemer for all indications ... Japan, and certain,indications worldwide. Crofelemer is Napo,s ... 3 trial for the treatment of,chronic diarrhea in ...
Cached Medicine News:Health News:Res-Q Gains Rights To Market Orosine - a Breakthrough, Patented, Natural Heart Supplement That Cardiologists Are Calling the 'Ultimate Cardio Protection' Against Heart Attacks, Strokes and Heart Failure. 2Health News:Global Med Technologies(R), Inc. Clarifies Proposal Received from Victory Park Capital Advisors, LLC 2Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 2Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 3Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 4Health News:Genomma Lab Announces 2009 Earnings Guidance 2Health News:Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals 2Health News:Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals 3Health News:Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals 4Health News:Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals 5
The Midas II Stainer is an automated slide stainer designed for use in hematology and microbiology laboratories....
... an "assembly-line worker" for routine staining protocols ... Programmable continuous slide stainer for routine stains. ... in short time. Its large number of ... working principle provides a high throughput. A ...
Cholesterol, Total. An automated analyzer test kits....
Intended for the quantitative determination of total cholesterol in serum. Reaction: Endpoint. Reaction complete within five minutes. Wavelength: 500 nm. Linearity: 700 mg/dL (18.1 mmol/L). Single st...
Medicine Products: